Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Autologous Cultured Keratinocyte Cell (Keraheal) for Severe Burn Wounds
NCT00978705Phase 3Unknown
- Sponsor
- Biosolution Co., Ltd.
- Start
- Nov 2007
- Primary completion
- May 2008
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous cultured keratinocytes in burn injury, sponsored by Biosolution Co., Ltd.. Status: unknown.
02
Drugs
autologous cultured keratinocytes
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00978705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978705.